Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis

Immune monitoring of functional responses is a fundamental parameter to establish correlates of protection in clinical trials evaluating vaccines and therapies to boost antigen-specific responses. The IFNg ELISPOT assay is a well-standardized and validated method for the determination of functional...

Full description

Saved in:
Bibliographic Details
Published inCells (Basel, Switzerland) Vol. 4; no. 1; pp. 1 - 18
Main Authors Santos, Radleigh, Buying, Alcinette, Sabri, Nazila, Yu, John, Gringeri, Anthony, Bender, James, Janetzki, Sylvia, Pinilla, Clemencia, Judkowski, Valeria A
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 24.12.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Immune monitoring of functional responses is a fundamental parameter to establish correlates of protection in clinical trials evaluating vaccines and therapies to boost antigen-specific responses. The IFNg ELISPOT assay is a well-standardized and validated method for the determination of functional IFNg-producing T-cells in peripheral blood mononuclear cells (PBMC); however, its performance greatly depends on the quality and integrity of the cryopreserved PBMC. Here, we investigate the effect of overnight (ON) resting of the PBMC on the detection of CD8-restricted peptide-specific responses by IFNg ELISPOT. The study used PBMC from healthy donors to evaluate the CD8 T-cell response to five pooled or individual HLA-A2 viral peptides. The results were analyzed using a modification of the existing distribution free resampling (DFR) recommended for the analysis of ELISPOT data to ensure the most rigorous possible standard of significance. The results of the study demonstrate that ON resting of PBMC samples prior to IFNg ELISPOT increases both the magnitude and the statistical significance of the responses. In addition, a comparison of the results with a 13-day preculture of PBMC with the peptides before testing demonstrates that ON resting is sufficient for the efficient evaluation of immune functioning.
AbstractList Immune monitoring of functional responses is a fundamental parameter to establish correlates of protection in clinical trials evaluating vaccines and therapies to boost antigen-specific responses. The IFNg ELISPOT assay is a well-standardized and validated method for the determination of functional IFNg-producing T-cells in peripheral blood mononuclear cells (PBMC); however, its performance greatly depends on the quality and integrity of the cryopreserved PBMC. Here, we investigate the effect of overnight (ON) resting of the PBMC on the detection of CD8-restricted peptide-specific responses by IFNg ELISPOT. The study used PBMC from healthy donors to evaluate the CD8 T-cell response to five pooled or individual HLA-A2 viral peptides. The results were analyzed using a modification of the existing distribution free resampling (DFR) recommended for the analysis of ELISPOT data to ensure the most rigorous possible standard of significance. The results of the study demonstrate that ON resting of PBMC samples prior to IFNg ELISPOT increases both the magnitude and the statistical significance of the responses. In addition, a comparison of the results with a 13-day preculture of PBMC with the peptides before testing demonstrates that ON resting is sufficient for the efficient evaluation of immune functioning.
Author Pinilla, Clemencia
Santos, Radleigh
Sabri, Nazila
Buying, Alcinette
Yu, John
Gringeri, Anthony
Janetzki, Sylvia
Bender, James
Judkowski, Valeria A
Author_xml – sequence: 1
  givenname: Radleigh
  surname: Santos
  fullname: Santos, Radleigh
  email: rsantos@tpims.org
  organization: Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway Port St. Lucie, FL 34987, USA. rsantos@tpims.org
– sequence: 2
  givenname: Alcinette
  surname: Buying
  fullname: Buying, Alcinette
  email: abunying@tpims.org
  organization: Torrey Pines Institute for Molecular Studies, 3550 General Atomics Court, San Diego, CA 92121, USA. abunying@tpims.org
– sequence: 3
  givenname: Nazila
  surname: Sabri
  fullname: Sabri, Nazila
  email: nsabri@tpims.org
  organization: Torrey Pines Institute for Molecular Studies, 3550 General Atomics Court, San Diego, CA 92121, USA. nsabri@tpims.org
– sequence: 4
  givenname: John
  surname: Yu
  fullname: Yu, John
  email: John.Yu@cshs.org
  organization: Cedars-Sinai, 8700 Beverly Blvd., Los Angeles, CA 90048, USA. John.Yu@cshs.org
– sequence: 5
  givenname: Anthony
  surname: Gringeri
  fullname: Gringeri, Anthony
  email: anthony.gringeri@imuc.com
  organization: ImmunoCellular Therapeutics Ltd., 23622 Calabasas Road, Calabasas, CA 91302, USA. anthony.gringeri@imuc.com
– sequence: 6
  givenname: James
  surname: Bender
  fullname: Bender, James
  email: james.bender@lionbio.com
  organization: ImmunoCellular Therapeutics Ltd., 23622 Calabasas Road, Calabasas, CA 91302, USA. james.bender@lionbio.com
– sequence: 7
  givenname: Sylvia
  surname: Janetzki
  fullname: Janetzki, Sylvia
  email: sylvia@zellnet.com
  organization: ZellNet Consulting, 555 North Ave., Fort Lee, NJ 07024, USA. sylvia@zellnet.com
– sequence: 8
  givenname: Clemencia
  surname: Pinilla
  fullname: Pinilla, Clemencia
  email: pinilla@tpims.org
  organization: Torrey Pines Institute for Molecular Studies, 3550 General Atomics Court, San Diego, CA 92121, USA. pinilla@tpims.org
– sequence: 9
  givenname: Valeria A
  surname: Judkowski
  fullname: Judkowski, Valeria A
  email: vjudkowski@tpims.org
  organization: Torrey Pines Institute for Molecular Studies, 3550 General Atomics Court, San Diego, CA 92121, USA. vjudkowski@tpims.org
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25546016$$D View this record in MEDLINE/PubMed
BookMark eNpdkUFvEzEQhS1UREvpjTOyxIUDAdvr9drHEjWwUiBRE84rxx5vNtq1g70pKj-BX41DSlVxmtHom6eZ916iMx88IPSakg9FochHA32fOKGEEPoMXTBSFRPOiTp70p-jq5R2mSCSCkrKF-iclSUXhIoL9Lse9jHcwQB-xMHhevatxTfzerVcrPESogtx0N4AnoW-Dz873-LFHUTftdsR30Iaj5O8N4vhF3i8_PR1ild62PeQ8DR418UBLF5vYzi0W3zbtSF3Ca9GPXZ52egeX3vd36cuvULPne4TXD3US_R9drOefpnMF5_r6fV8YpiQdKKNZEYJpklhHSGc0Y0xqhBSGighe0EJUOu40kCFqCoLZmOZBS2oEo5WxSWqT7o26F2zj92g430TdNf8HYTYNjrm03poKk24dJZxzjS3REgmuFQbB4RrYiuZtd6dtLKJPw7Zjmbo0jEU7SH_2VDBKVWKU57Rt_-hu3CI-fcjVTGpWCnKTL0_USaGlCK4xwMpaY6RN08jz_ibB9HDJhv9CP8LuPgDwOqoVg
CitedBy_id crossref_primary_10_18632_oncotarget_4772
crossref_primary_10_1186_s40425_019_0576_2
crossref_primary_10_3389_fimmu_2024_1382192
crossref_primary_10_1186_s40425_016_0178_1
crossref_primary_10_1208_s12248_023_00814_5
crossref_primary_10_3390_cells4020133
crossref_primary_10_1158_1078_0432_CCR_19_0261
crossref_primary_10_3389_fimmu_2020_576756
crossref_primary_10_1111_myc_12780
crossref_primary_10_1208_s12248_023_00861_y
crossref_primary_10_14302_issn_2572_3030_jcgb_18_2527
crossref_primary_10_1002_adfm_202007017
crossref_primary_10_1038_nprot_2015_068
crossref_primary_10_1016_S2666_5247_23_00324_5
crossref_primary_10_1016_j_omtm_2019_07_008
crossref_primary_10_1186_s40425_015_0074_0
Cites_doi 10.1016/j.jim.2010.05.005
10.1128/CVI.00435-06
10.1371/journal.pone.0076215
10.1007/978-1-61779-325-7_2
10.1038/ni.f.219
10.1007/s00262-010-0875-4
10.1007/s00262-014-1593-0
10.1002/eji.200323844
10.1186/1479-5876-9-26
10.1007/s00262-007-0378-0
10.1038/ni.2703
10.1038/nature01146
10.1126/scitranslmed.3002785
10.1016/j.jim.2007.02.003
10.1007/s00262-009-0788-2
10.1016/j.jim.2008.10.019
10.1128/CDLI.8.5.871-879.2001
10.1007/s00262-007-0380-6
10.1186/1479-5876-2-9
10.1089/aid.2006.0129
10.1016/S0022-1759(01)00535-X
10.1182/blood-2010-12-319780
10.1007/s00262-012-1359-5
10.1111/j.1365-2249.2010.04272.x
10.1371/journal.pone.0014330
10.1016/j.vaccine.2007.10.061
10.1016/j.jim.2010.03.001
10.1016/j.immuni.2012.07.010
10.3390/cells1030409
10.1016/j.jim.2006.07.015
ContentType Journal Article
Copyright Copyright MDPI AG 2015
Copyright_xml – notice: Copyright MDPI AG 2015
DBID NPM
AAYXX
CITATION
8FD
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
GNUQQ
HCIFZ
LK8
M7P
P64
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
RC3
7X8
DOA
DOI 10.3390/cells4010001
DatabaseName PubMed
CrossRef
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
Biological Sciences
Biological Science Database
Biotechnology and BioEngineering Abstracts
Access via ProQuest (Open Access)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
Biotechnology and BioEngineering Abstracts
ProQuest Central
Genetics Abstracts
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
Engineering Research Database
ProQuest One Academic
MEDLINE - Academic
DatabaseTitleList PubMed

Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2073-4409
EndPage 18
ExternalDocumentID oai_doaj_org_article_7a048fd2442a4d06826489bfe04a0d78
3653672921
10_3390_cells4010001
25546016
Genre Journal Article
GroupedDBID 53G
5VS
8FE
8FH
AADQD
AAFWJ
ABDBF
ADBBV
ADRAZ
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
DIK
EBD
ESX
GROUPED_DOAJ
HCIFZ
HYE
IPNFZ
KQ8
LK8
M48
M7P
MODMG
M~E
NPM
OK1
PGMZT
PIMPY
PROAC
RIG
RPM
AAYXX
CITATION
8FD
ABUWG
AZQEC
DWQXO
FR3
GNUQQ
P64
PQEST
PQQKQ
PQUKI
PRINS
RC3
7X8
ID FETCH-LOGICAL-c2681-ac82c962a03df00421bcc93688ce5e40110e1df49ae16677decbd2dea6196f173
IEDL.DBID M48
ISSN 2073-4409
IngestDate Tue Oct 22 15:14:30 EDT 2024
Sat Aug 17 03:41:46 EDT 2024
Thu Oct 10 16:38:39 EDT 2024
Fri Aug 23 00:29:06 EDT 2024
Sat Sep 28 07:56:46 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2681-ac82c962a03df00421bcc93688ce5e40110e1df49ae16677decbd2dea6196f173
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.proquest.com/docview/1672892565?pq-origsite=%requestingapplication%
PMID 25546016
PQID 1672892565
PQPubID 2032536
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_7a048fd2442a4d06826489bfe04a0d78
proquest_miscellaneous_1641199414
proquest_journals_1672892565
crossref_primary_10_3390_cells4010001
pubmed_primary_25546016
PublicationCentury 2000
PublicationDate 2014-Dec-24
PublicationDateYYYYMMDD 2014-12-24
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-Dec-24
  day: 24
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Cells (Basel, Switzerland)
PublicationTitleAlternate Cells
PublicationYear 2014
Publisher MDPI AG
Publisher_xml – name: MDPI AG
References 24146841 - PLoS One. 2013 Oct 11;8(10):e76215
17263637 - AIDS Res Hum Retroviruses. 2007 Jan;23(1):86-92
17382342 - J Immunol Methods. 2007 Apr 30;322(1-2):57-69
16959262 - J Immunol Methods. 2006 Aug 31;315(1-2):121-32
12459785 - Nature. 2002 Nov 28;420(6914):429-34
21931118 - Blood. 2011 Dec 22;118(26):6772-82
24048123 - Nat Immunol. 2013 Oct;14(10):1014-22
25906398 - Cells. 2015;4(2):133-4
12731046 - Eur J Immunol. 2003 May;33(5):1215-23
11792386 - J Immunol Methods. 2002 Feb 1;260(1-2):157-72
21179404 - PLoS One. 2010 Dec 14;5(12):e14330
17376862 - Clin Vaccine Immunol. 2007 May;14(5):527-37
11527795 - Clin Diagn Lab Immunol. 2001 Sep;8(5):871-9
21956498 - Methods Mol Biol. 2012;792:25-36
25134947 - Cancer Immunol Immunother. 2014 Nov;63(11):1199-211
19148199 - Nat Immunol. 2009 Feb;10(2):143-7
20939860 - Clin Exp Immunol. 2011 Jan;163(1):33-49
15050026 - J Transl Med. 2004 Mar 29;2(1):9
22072636 - Sci Transl Med. 2011 Nov 9;3(108):108ps44
20549207 - Cancer Immunol Immunother. 2010 Oct;59(10):1489-501
18055072 - Vaccine. 2008 Jan 10;26(2):215-23
24710483 - Cells. 2012 Jul 30;1(3):409-27
19894047 - Cancer Immunol Immunother. 2010 Apr;59(4):609-18
19041316 - J Immunol Methods. 2009 Feb 28;341(1-2):68-75
22840835 - Immunity. 2012 Jul 27;37(1):1-2
21385453 - J Transl Med. 2011 Mar 08;9:26
20214906 - J Immunol Methods. 2010 May 31;357(1-2):51-4
20641145 - J Immunol Methods. 2010 Jul 31;359(1-2):28-36
17721781 - Cancer Immunol Immunother. 2008 Mar;57(3):303-15
17721783 - Cancer Immunol Immunother. 2008 Mar;57(3):289-302
23138872 - Cancer Immunol Immunother. 2013 Apr;62(4):615-27
ref13
ref12
ref15
ref14
ref31
ref30
ref11
ref33
ref10
ref32
ref2
Janetzki (ref1) 2012
ref19
ref18
ref24
ref23
ref26
ref25
ref20
Smith (ref9) 2001; 8
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref4
ref3
ref6
ref5
Janetzki (ref17) 2012; 792
Van der Burg (ref16) 2011; 3
References_xml – ident: ref5
  doi: 10.1016/j.jim.2010.05.005
– ident: ref11
  doi: 10.1128/CVI.00435-06
– ident: ref18
  doi: 10.1371/journal.pone.0076215
– volume: 792
  start-page: 25
  year: 2012
  ident: ref17
  article-title: The impact of harmonization on ELISPOT assay performance
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-61779-325-7_2
  contributor:
    fullname: Janetzki
– ident: ref24
  doi: 10.1038/ni.f.219
– ident: ref19
  doi: 10.1007/s00262-010-0875-4
– ident: ref32
  doi: 10.1007/s00262-014-1593-0
– ident: ref22
– ident: ref25
  doi: 10.1002/eji.200323844
– ident: ref6
  doi: 10.1186/1479-5876-9-26
– ident: ref15
  doi: 10.1007/s00262-007-0378-0
– ident: ref33
  doi: 10.1038/ni.2703
– ident: ref23
  doi: 10.1038/nature01146
– volume: 3
  start-page: 108ps44
  year: 2011
  ident: ref16
  article-title: Harmonization of immune biomarker assays for clinical studies
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.3002785
  contributor:
    fullname: Van der Burg
– ident: ref3
  doi: 10.1016/j.jim.2007.02.003
– ident: ref10
  doi: 10.1007/s00262-009-0788-2
– ident: ref7
  doi: 10.1016/j.jim.2008.10.019
– volume: 8
  start-page: 871
  year: 2001
  ident: ref9
  article-title: Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus
  publication-title: Clin. Diagnost. Lab. Immunol.
  doi: 10.1128/CDLI.8.5.871-879.2001
  contributor:
    fullname: Smith
– ident: ref14
  doi: 10.1007/s00262-007-0380-6
– ident: ref29
  doi: 10.1186/1479-5876-2-9
– ident: ref26
– ident: ref4
  doi: 10.1089/aid.2006.0129
– ident: ref21
  doi: 10.1016/S0022-1759(01)00535-X
– ident: ref13
  doi: 10.1182/blood-2010-12-319780
– ident: ref8
  doi: 10.1007/s00262-012-1359-5
– ident: ref2
  doi: 10.1111/j.1365-2249.2010.04272.x
– ident: ref30
  doi: 10.1371/journal.pone.0014330
– ident: ref31
  doi: 10.1016/j.vaccine.2007.10.061
– ident: ref12
  doi: 10.1016/j.jim.2010.03.001
– start-page: 419
  year: 2012
  ident: ref1
  article-title: Immune Monitoring Design within the Developmental Pipeline for an Immunotherapeutic or Preventive Vaccine
  contributor:
    fullname: Janetzki
– ident: ref20
  doi: 10.1016/j.immuni.2012.07.010
– ident: ref27
  doi: 10.3390/cells1030409
– ident: ref28
  doi: 10.1016/j.jim.2006.07.015
SSID ssj0000816105
Score 1.9628258
Snippet Immune monitoring of functional responses is a fundamental parameter to establish correlates of protection in clinical trials evaluating vaccines and therapies...
SourceID doaj
proquest
crossref
pubmed
SourceType Open Website
Aggregation Database
Index Database
StartPage 1
SubjectTerms IFNg ELISPOT
immune monitoring
overnight resting
PBMC
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS-RAEG5EWPAi666PrK60oMdgOunncRWDio9BR_AWutMd8ZIsM7Ms-hP81Val4zgeZC97C0mHFPVIf9VUfUXIvlVBu1qIVGC4cWaa1DimU24FZ0z5UGjsHb68kqd3_Pxe3C-M-sKasEgPHBV3qCz4WONhF8ot95nUWJJlXBMybjOvYptvZhaSqf4frAHJZCJWuheQ1x_iOfgUkgkENR_2oJ6q_3N82e8z5VeyOgBE-isKtkaWQvuNfIkjI5--k5d4CtAf6tGuoWfl1QM9uTi7HV2P6ei9C4CWYODuL2xM9Bqn6WIOTm-QUgPuwHvlpHsOLR0dXR7TW4sUwVOK3X-PE5CJjuP0Hnrz-NDB1ZQiJu0pnVG0gcdkndyVJ-Pj03SYp5DWudQstbXOayNzmxW-wWhlrq5NIbWugwgckUBgvuHGBialAkPVzuc-WEiyZMNUsUGW264NW4QKqRyAjyxrlOfOOisKriHXUtiIKwNLyMGbhqvfkTajgnQDLVEtWiIhR6j--Roku-5vgAtUgwtU_3KBhOy8Ga8aInBaMakglwRAJxKyN38MsYOft20A3cEa8EdjOOMJ2YxGn0uSY_ke4OEf_0PCbbICQKsniMz5DlmeTf6EnwBmZm6399tXROTwoA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgKyQuiHdTCjISHKPGiV85IbbaqEV0u9pupd4iv7LqJSmbIlR-Ar-amcS7hQPcIsdJLI_H_r7JPAj5YFTQ1gmRClQ3zsomLS3TKTeCM6Z8KDTGDp_N5ckl_3IlrqLBrY9ulds9cdiofefQRn7EpAJuAAe0-HTzLcWqUfh3NZbQeEj2cmAK-YTsTWfzxXJnZcGyEoAgRo_3Avj9EdrDeyAVCG7-OouGlP3_xpnDeVM9JU8iUKSfR8k-Iw9C-5w8GktH3r0gv0ZrwGDco11DT6v5ms6-nl4szld0cR8NQCsQdPcDDih6jlV1kYvTJabWgBZ4rtp0P0NLF9OzY3phMFVwTzEK8HoDY6KrsYoPXV6vO7jqKWLTIbUzDi3mM3lJLqvZ6vgkjXUVUpdLzVLjdO5KmZus8A1qLbPOlYXU2gUROCKCwHzDSxOYlAoE5qzPfTBAtmTDVPGKTNquDfuECqksgJAsa5Tn1lgjCq6BcykMyJWBJeTjdobrmzF9Rg20AyVR_ymJhExx-nd9MOn10NBt1nXUoVoZ2G4aD4AkN9xnUqN3XmmbkHGTeaUTcrgVXh01sa_v101C3u9ugw7h500bYO6gD6zLsuSMJ-T1KPTdSHJ04wNcfPD_l78hjwFKDSkgc35IJreb7-EtwJVb-y6uyd9JP-oy
  priority: 102
  providerName: ProQuest
Title Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/25546016
https://www.proquest.com/docview/1672892565
https://search.proquest.com/docview/1641199414
https://doaj.org/article/7a048fd2442a4d06826489bfe04a0d78
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Na9wwEB3ShEIvpd9xmi4qtEe3li1L8iGUbliTlGazbHYhNyPb8hIodutNyMdP6K_ujGxvA21uRpZtoZmx3hOjNwAfjLI6L-LYjyncBE8qP8m59oWJBeeqtJGms8MnU3m0FN_O4_MtGKqN9hO4_i-1o3pSy_bHp5tft18w4A-IcSJl_0xb3GvkCYRXHsFOSJJclMTXA333T9aIbFw-Y4g-7QtkNV0W_D8vIHVgytwKqAL6vaXKKfo_DEPdcpQ-g6c9jmRfO8M_hy1bv4DHXWXJ25fwu9sscHt_rKnYcTpdscn347PZ6YLN_h4WYCn6QXON6xc7paK7RNXZnJQ3sAWfS9vmztZsNj45ZGeGlITXjA4JXrQ4Jrboivyw-cWqwas1I-jqlJ9paL3cyStYppPF4ZHfl13wi1Bq7ptCh0UiQxNEZUVBzfOiSCKpdWFjKwgwWF5WIjGWS6nQnkVehqU1yMVkxVX0Grbrpra7wGKpcsQoQVCpUuQmN3EkNFIyRed1peUefBxmOPvZqWtkyErIKNl9o3gwpunf9CFNbNfQtKusD7FMGfwbVSXildCIMpCakveSvLKBMEGptAf7g_Gywc8yLhVSTsR9sQfvN7cxxOjzprY4d9gH3TZJBBcevOmMvhnJ4Ct7D955C08QZDlxyFDsw_Zle2XfIZC5zEewM55MZ_OR2wgYOY_9A4gm778
link.rule.ids 315,783,787,867,2109,2228,21402,24332,27938,27939,33758,33759,43819,74638
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgE4IXxOcIDDASPEaLE8d2nhCdGrXQdlXXSXuL_JVqL8lohhD8CfzV3CVuBw_wFjlOYvnufL-72L8j5L2WXhmb53GO5sZZUceFYSrmOueMSeczhWeH5wsxueCfL_PLkHDrwrbK3ZrYL9SutZgjP2FCQmwADjr_eP01xqpR-Hc1lNC4Sw6Rqgq0-nA0XixX-ywLlpUABDHseM8gvj_BfHgHQQWCm798UU_Z_2-c2fub8hF5GIAi_TRI9jG545sn5N5QOvLHU_JryAb0yT3a1nRaLjZ0PJueL8_WdHl7GoCWIOj2OzgoeoZVdTEWpyuk1oAWeK7ctj99Q5ej-Sk910gV3FE8BXi1hTHR9VDFh66uNi1cdRSxaU_tjEMLfCbPyEU5Xp9O4lBXIbapUCzWVqW2EKlOMlej1TJjbZEJpazPPUdE4JmreaE9E0KCwKxxqfMagi1RM5k9JwdN2_gXhOZCGgAhSVJLx402Os-4gphL4oFc4VlEPuxmuLoe6DMqCDtQEtWfkojICKd_3wdJr_uGdrupgg1VUsNyUzsAJKnmLhEKd-cVpvYJ14mTKiLHO-FVwRK76lZvIvJufxtsCD-vGw9zB31AL4uCMx6Ro0Ho-5GkuI0PcPHL_7_8Lbk_Wc9n1Wy6-PKKPABY1dNBpvyYHNxsv_nXAF1uzJugn78Bji3tLA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9BJxAviG8CA4wEj1HjxLGdJ0RHoxW2Luo6aW-REzvVXpLRbprgT-Cv5i5xO3iAt8hxEst35_vd5T4APhjldFWnaZiSuAmeNWFWcR0KkwrOlXWJptzh47k8PBNfz9NzH_-08WGV2zOxP6htV5OPfMylQtsAFXQ6bnxYRPEl_3T5PaQOUvSn1bfTuAt7SiBXjWBvMp0Xi53HhVpMIJoYot8TtPXH5BvfoIFBQOcvvdSX7_835ux1T_4IHnrQyD4PVH4Md1z7BO4NbSR_PIVfg2egd_SxrmGzfL5i06PZaXGyZMVtZgDLkejdDSordkIddskuZwsqs4Ej-Fy-7n66lhWT4wN2aqhs8IZRRuDFGtfElkNHH7a4WHV4tWGEU_syz7Q0X9vkGZzl0-XBYeh7LIR1LDUPTa3jOpOxiRLbkATzqq6zRGpdu9QJQgeO20ZkxnEpFRKvrmxsnUHDSzZcJc9h1HatewkslapCQBJFjbKiMpVJE6HR_lKUnCsdD-DjdofLy6GURokmCFGi_JMSAUxo-3dzqAB2P9CtV6WXp1IZPHoai-AkNsJGUlOkXlY1LhImskoHsL8lXumlclPe8lAA73e3UZ7o86Z1uHc4B3k0ywQXAbwYiL5bSUwhfYiRX_3_5e_gPrJmeTSbf3sNDxBh9ZUhY7EPo6v1tXuDKOaqeuvZ8zeVofFg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improvement+of+IFNg+ELISPOT+Performance+Following+Overnight+Resting+of+Frozen+PBMC+Samples+Confirmed+Through+Rigorous+Statistical+Analysis&rft.jtitle=Cells+%28Basel%2C+Switzerland%29&rft.au=Santos%2C+Radleigh&rft.au=Buying%2C+Alcinette&rft.au=Sabri%2C+Nazila&rft.au=Yu%2C+John&rft.date=2014-12-24&rft.issn=2073-4409&rft.eissn=2073-4409&rft.volume=4&rft.issue=1&rft.spage=1&rft_id=info:doi/10.3390%2Fcells4010001&rft_id=info%3Apmid%2F25546016&rft.externalDocID=25546016
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2073-4409&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2073-4409&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2073-4409&client=summon